RxDoctor Payments Data

Kenneth Hung, MD

Gastroenterology · New Haven, CTNPI 1609219278

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Gilead at 43.0% of the total. Reporting peaked in 2019 at $345 and has fallen 77.4% since, to $78 in 2024. That places this record below the midpoint for gastroenterology clinicians in CT, where the typical reported total is $3,356.

$465in general payments, 2019–2025

Across 7 payments — averaging $66.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$200
  • Pfizer$145
  • Medtronic$78
  • Alnylam Pharmaceuticals Inc.$42
$241,164in research payments, 2019–2025

Across 5 payments — averaging $48,233 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$241K

What the payments were for

  • Food & beverage$465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead4$200
Pfizer1$145
Medtronic1$78
Alnylam Pharmaceuticals Inc.1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$465 in reported general payments places this provider in the 20th percentile of 326 gastroenterology providers in Connecticut.

See all gastroenterology providers in Connecticut

Medicare billing

Part B allowed, 2024
$51,986
Medicare patients
240
Services billed
443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →